it’s actually $1b “EBITDA” not revenue...
revenue is over $2.5b for the 11 year base case
monster!!
- Forums
- ASX - By Stock
- IXR
- Ann: Makuutu Rare Earths Project Scoping Study
Ann: Makuutu Rare Earths Project Scoping Study, page-16
-
- There are more pages in this discussion • 388 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $50.72M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $22.73K | 2.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 13431258 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 10441275 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 13431258 | 0.010 |
36 | 17965575 | 0.009 |
13 | 7190627 | 0.008 |
10 | 6457314 | 0.007 |
7 | 6085000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 10441275 | 4 |
0.012 | 5136901 | 15 |
0.013 | 3314749 | 6 |
0.014 | 2909137 | 7 |
0.015 | 3521454 | 8 |
Last trade - 13.56pm 15/07/2024 (20 minute delay) ? |
Featured News
IXR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online